{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,11]],"date-time":"2025-12-11T20:39:53Z","timestamp":1765485593465,"version":"build-2065373602"},"reference-count":33,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2012,7,1]],"date-time":"2012-07-01T00:00:00Z","timestamp":1341100800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,7,1]],"date-time":"2012-07-01T00:00:00Z","timestamp":1341100800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["celltherapyjournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytotherapy"],"published-print":{"date-parts":[[2012,7]]},"DOI":"10.3109\/14653249.2012.663486","type":"journal-article","created":{"date-parts":[[2012,3,12]],"date-time":"2012-03-12T06:19:37Z","timestamp":1331533177000},"page":"724-732","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"title":["Clinical-grade varicella zoster virus-specific T cells produced for adoptive immunotherapy in hemopoietic stem cell transplant recipients"],"prefix":"10.1016","volume":"14","author":[{"given":"Emily","family":"Blyth","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shivashni S.","family":"Gaundar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leighton","family":"Clancy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Renee M.","family":"Simms","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ian","family":"Bilmon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenneth P.","family":"Micklethwaite","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David J.","family":"Gottlieb","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.3109\/14653249.2012.663486_bib0005","article-title":"Varicella-Zoster Virus: Virology and Clinical Management","author":"Arvin","year":"2000","journal-title":"Cambridge: Cambridge University Press"},{"key":"10.3109\/14653249.2012.663486_bib0010","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.ijid.2003.09.006","article-title":"A review of the varicella vaccine in immunocompromised individuals","volume":"8","author":"Sartori","year":"2004","journal-title":"Int J Infect Dis"},{"key":"10.3109\/14653249.2012.663486_bib0015","doi-asserted-by":"crossref","first-page":"e525","DOI":"10.1542\/peds.2005-0219","article-title":"Recent steroid therapy increases severity of varicella infections in children with acute lymphoblastic leukemia","volume":"116","author":"Hill","year":"2005","journal-title":"Pediatrics"},{"key":"10.3109\/14653249.2012.663486_bib0020","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1017\/S0950268810003031","article-title":"Dynamics in children and adolescents who experience varicella zoster virus infections after haematopoietic stem cell transplantation: a case-control study","volume":"139","author":"Ayta\u00e7","year":"2011","journal-title":"Epidemiol Infect"},{"key":"10.3109\/14653249.2012.663486_bib0025","doi-asserted-by":"crossref","first-page":"3071","DOI":"10.1182\/blood-2007-03-077644","article-title":"One-year acyclovir prophylaxis for preventing varicella-zoster virus disease after hematopoietic cell transplantation: no evidence of rebound varicella-zoster virus disease after drug discontinuation","volume":"110","author":"Erard","year":"2007","journal-title":"Blood"},{"key":"10.3109\/14653249.2012.663486_bib0030","first-page":"155","article-title":"Varicella zoster virus immune evasion strategies","volume":"342","author":"Abendroth","year":"2010","journal-title":"Curr Top Microbiol Immunol"},{"key":"10.3109\/14653249.2012.663486_bib0035","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1111\/j.1348-0421.2000.tb02599.x","article-title":"IL-12, IFN-gamma, and TNF-alpha released from mononuclear cells inhibit the spread of varicella-zoster virus at an early stage of varicella","volume":"44","author":"Torigo","year":"2000","journal-title":"Microbiol Immunol"},{"key":"10.3109\/14653249.2012.663486_bib0040","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1086\/515702","article-title":"Interleukin (IL)-10, IL-12, and interferon-gamma production in primary and memory immune responses to varicella-zoster virus","volume":"178","author":"Jenkins","year":"1998","journal-title":"J Infect Dis"},{"key":"10.3109\/14653249.2012.663486_bib0045","first-page":"341","article-title":"VZV T cell-mediated immunity","volume":"342","author":"Weinberg","year":"2010","journal-title":"Curr Top Microbiol Immunol"},{"key":"10.3109\/14653249.2012.663486_bib0050","doi-asserted-by":"crossref","first-page":"7087","DOI":"10.1016\/j.vaccine.2007.07.051","article-title":"Phenotypic and functional characterization of ex vivo T cell responses to the live attenuated herpes zoster vaccine","volume":"25","author":"Patterson-Bartlett","year":"2007","journal-title":"Vaccine"},{"key":"10.3109\/14653249.2012.663486_bib0055","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1111\/j.1365-2249.1994.tb06618.x","article-title":"Cytokine production in varicella zoster virus-stimulated limiting dilution lymphocyte cultures","volume":"98","author":"Zhang","year":"1994","journal-title":"Clin Exp Immunol"},{"key":"10.3109\/14653249.2012.663486_bib0060","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1542\/peds.18.1.109","article-title":"Disturbances in gamma globulin synthesis as experiments of nature","volume":"18","author":"Good","year":"1956","journal-title":"Pediatrics"},{"key":"10.3109\/14653249.2012.663486_bib0065","doi-asserted-by":"crossref","first-page":"2648","DOI":"10.1056\/NEJMc071043","article-title":"Varicella vaccine","volume":"356","author":"Gershon","year":"2007","journal-title":"N Engl J Med"},{"key":"10.3109\/14653249.2012.663486_bib0070","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1056\/NEJMoa013441","article-title":"Use of an inactivated varicella vaccine in recipients of hematopoietic-cell transplants","volume":"347","author":"Hata","year":"2002","journal-title":"N Engl J Med"},{"key":"10.3109\/14653249.2012.663486_bib0075","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1182\/blood-2009-08-239186","article-title":"Long term outcome of EBV specific T-cell infusions to prevent or treat EBV-related lymphoproliferative disease in transplant recipients","volume":"115","author":"Heslop","year":"2010","journal-title":"Blood"},{"key":"10.3109\/14653249.2012.663486_bib0080","doi-asserted-by":"crossref","first-page":"4283","DOI":"10.1182\/blood-2009-07-232454","article-title":"Cytotoxic T lymphocyte therapy with donor T cells prevents and treats adenovirus and Epstein\u2013Barr virus infections after haploidentical and matched unrelated stem cell transplantation","volume":"114","author":"Leen","year":"2009","journal-title":"Blood"},{"key":"10.3109\/14653249.2012.663486_bib0085","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.bbmt.2003.09.017","article-title":"Adoptive immunotherapy for posttransplantation viral infections","volume":"10","author":"Bollard","year":"2004","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.3109\/14653249.2012.663486_bib0090","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.bbmt.2007.02.004","article-title":"Ex-vivo expansion and prophylactic infusion of CMV-pp65 peptide specific cytotoxic T-lymphocytes following allogeneic haemopoietic stem cell transplantation","volume":"13","author":"Micklethwaite","year":"2007","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.3109\/14653249.2012.663486_bib0095","doi-asserted-by":"crossref","first-page":"3974","DOI":"10.1182\/blood-2008-06-161695","article-title":"Prophylactic infusion of cytomegalovirus-specific cytotoxic T lymphocytes stimulated with Ad5f35pp65 gene-modified dendritic cells after allogeneic hemopoietic stem cell transplantation","volume":"112","author":"Micklethwaite","year":"2008","journal-title":"Blood"},{"key":"10.3109\/14653249.2012.663486_bib0100","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1097\/TP.0b013e31823328c0","article-title":"BK virus specific T cells for use in cellular therapy show specificity to multiple antigens and polyfunctional cytokine responses","volume":"92","author":"Blyth","year":"2011","journal-title":"Transplantation"},{"key":"10.3109\/14653249.2012.663486_bib0105","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S0022-1759(03)00265-5","article-title":"Sensitive and viable identification of antigen-specific CD8 + T cells by a flow cytometric assay for degranulation","volume":"281","author":"Betts","year":"2003","journal-title":"J Immunol Methods"},{"key":"10.3109\/14653249.2012.663486_bib0110","doi-asserted-by":"crossref","first-page":"5102","DOI":"10.1128\/JCM.43.10.5102-5110.2005","article-title":"Development of multiplex PCRs for detection of common viral pathogens and agents of congenital infections","volume":"43","author":"McIver","year":"2005","journal-title":"J Clin Microbiol"},{"key":"10.3109\/14653249.2012.663486_bib0115","doi-asserted-by":"crossref","first-page":"182","DOI":"10.3109\/14653249.2011.613932","article-title":"In vitro generation of influenza-specific polyfunctional CD4 + T cells suitable for adoptive immunotherapy","volume":"14","author":"Gaundar","year":"2011","journal-title":"Cytotherapy"},{"key":"10.3109\/14653249.2012.663486_bib0120","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1182\/blood.V75.3.806.bloodjournal753806","article-title":"Studies on transfer of varicella-zoster-virus specific T-cell immunity from bone marrow donor to recipient","volume":"75","author":"Kato","year":"1990","journal-title":"Blood"},{"key":"10.3109\/14653249.2012.663486_bib0125","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1038\/sj.bmt.1705673","article-title":"Safety of vaccinating sibling donors with live-attenuated varicella zoster vaccine before hematopoietic stem cell transplantation","volume":"39","author":"Leung","year":"2007","journal-title":"Bone Marrow Transplant"},{"key":"10.3109\/14653249.2012.663486_bib0130","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.coi.2009.02.010","article-title":"Adoptive transfer of virus-specific and tumor-specific T cell immunity","volume":"21","author":"Berger","year":"2009","journal-title":"Curr Opin Immunol"},{"key":"10.3109\/14653249.2012.663486_bib0135","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.4049\/jimmunol.174.2.1037","article-title":"Functional heterogeneity of memory CD4 T cell responses in different conditions of antigen exposure and persistence","volume":"174","author":"Harari","year":"2005","journal-title":"J Immunol"},{"key":"10.3109\/14653249.2012.663486_bib0140","doi-asserted-by":"crossref","first-page":"257","DOI":"10.4049\/jimmunol.146.1.257","article-title":"Equivalent recognition of a varicella-zoster virus immediate early protein (IE62) and glycoprotein I by cytotoxic T lymphocytes of either CD4+ or CD8+ phenotype","volume":"146","author":"Arvin","year":"1991","journal-title":"J Immunol"},{"key":"10.3109\/14653249.2012.663486_bib0145","doi-asserted-by":"crossref","first-page":"2713","DOI":"10.1128\/JVI.01830-06","article-title":"Changes in paracrine interleukin-2 requirement, CCR7 expression, frequency, and cytokine secretion of human immunodeficiency virus-specific CD4 + T cells are a consequence of antigen load","volume":"81","author":"Tilton","year":"2007","journal-title":"J Virol"},{"key":"10.3109\/14653249.2012.663486_bib0150","doi-asserted-by":"crossref","first-page":"8335","DOI":"10.1158\/0008-5472.CAN-06-4426","article-title":"Gene-engineered varicella-zoster virus reactive CD4 + cytotoxic T cells exert tumor-specific effector function","volume":"67","author":"Landmeier","year":"2007","journal-title":"Cancer Res"},{"key":"10.3109\/14653249.2012.663486_bib0155","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1111\/j.1399-3046.2005.00419.x","article-title":"Specific autologous cytotoxic T lymphocytes for chronic varicella in a liver transplanted child","volume":"10","author":"Melzi","year":"2006","journal-title":"Pediatr Transplant"},{"key":"10.3109\/14653249.2012.663486_bib0160","doi-asserted-by":"crossref","first-page":"3146","DOI":"10.1182\/blood-2009-07-234906","article-title":"Allo-HLA reactivity of virus-specific memory T cells is common","volume":"115","author":"Amir","year":"2010","journal-title":"Blood"},{"key":"10.3109\/14653249.2012.663486_bib0165","doi-asserted-by":"crossref","first-page":"4700","DOI":"10.1182\/blood-2010-06-289991","article-title":"Allogeneic virus-specific T cells with HLA alloreactivity do not produce GVHD in human subjects","volume":"116","author":"Melenhorst","year":"2010","journal-title":"Blood"}],"container-title":["Cytotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1465324912706874?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1465324912706874?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T22:16:20Z","timestamp":1761430580000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1465324912706874"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,7]]},"references-count":33,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2012,7]]}},"alternative-id":["S1465324912706874"],"URL":"https:\/\/doi.org\/10.3109\/14653249.2012.663486","relation":{},"ISSN":["1465-3249"],"issn-type":[{"type":"print","value":"1465-3249"}],"subject":[],"published":{"date-parts":[[2012,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical-grade varicella zoster virus-specific T cells produced for adoptive immunotherapy in hemopoietic stem cell transplant recipients","name":"articletitle","label":"Article Title"},{"value":"Cytotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.3109\/14653249.2012.663486","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 International Society for Cellular Therapy. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}